Expression of Multidrug Resistant Gene (mdr-1/P-glycoprotein) in a Megakaryoblastic Cell Line, CMK, and its Enhancement During Megakaryocytic Differentiation

References

• Endicott J.A., Ling V. The biochemistry of P-glyco-protein-mediated multidrug resistance. Annu. Rev. Biochem. 1989; 58: 137–171
   PubMed Web of Science ®Google Scholar
• Harber D. Multidrug resistance (MDR 1) in leukemia: is it time to test?. Blood 1992; 79: 295–298
   PubMed Web of Science ®Google Scholar
• Thiebaut F., Tsuruo T., Hamada T., Gottesman M.M., Pastan I., Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 1987; 84: 7735–7738
   PubMed Web of Science ®Google Scholar
• Fojo A.T., Ueda K., Slamon D.L., Poplack D.G., Gottesman M.M., Psatan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc., Natl. Acad. Sci. USA 1987; 84: 265–269
   PubMed Web of Science ®Google Scholar
• Noornan K.E., Beck C., Holzmayer T.A., Chin L.E., Wunder J.S., Andrulis I.L., Gazder A F., Willman C.L., von Griftith B., Hoff D.D., Roninson I.B. Quantitative analysis of MDR 1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA 1990; 87: 7150–7164
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C., O'Brian J.P, Casals D., Ritter-Grauer L., Biedler J.L., Melamed anti M.R., Bertino J.R. Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood brain barrier sites. Proc. Natl. Acad. Sci. USA 1989; 86: 695–698
   PubMed Web of Science ®Google Scholar
• Chin K-V., Ueda K., Pastan I., Gottesman M.M. Modulation of the promoter of the human MDR1 genes by Ras and p53. Science 1992; 255: 459–462
   PubMed Web of Science ®Google Scholar
• Benerjee S., Ganapathi R., Ghosh R., Yu C.L. Down-regulation of ras and myc expression associated with mdr-1 over-expression in adriamycin-resistant tumor cells. Cell. Mol. Bio. 1992; 38: 561–570
   Web of Science ®Google Scholar
• Goldstein D., Laszlo J. Interferon therapy in cancer: From imagination to interferon. Cancer Res. 1986; 46: 4315–4329
   PubMed Web of Science ®Google Scholar
• Quesada J.R., Reuben J., Manning J.T., Hersh E.M., Gutterman J.U. Alpha interferon for induction of remission in hairly-cell leukemia. N. Engl. J. Med. 1984; 310: 15–18
   PubMed Web of Science ®Google Scholar
• Tricot G., De Bock R., Boogarerts M.A., Peetermans M., Punt K., Verwilghen R.L. Low dosecytosine arabinoside (Ara C) in myelodysplastic syndromes. Br. J. Haematol. 1984; 58: 231–240
   PubMed Web of Science ®Google Scholar
• Cheson B.D., Jasperse D.M., Simon R., Friedman M.A. A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. J. Clin. Oncol. 1986; 4: 1857–1864
   PubMed Web of Science ®Google Scholar
• Picozzi V.J., Jr., Swanson G.F., Morgan R., Hecht F., Greenberg P.L. 13-cis retinoic acid treatment for myelodysplastic syndromes. J. Clin. Oncol. 1986; 4: 589–595
   PubMed Web of Science ®Google Scholar
• Warrell R.P., Jr., Frankel S.R., Miller W.H., Jr., Scheinberg D.A., Itri L.M., Hittelman W.N., Vyas R., Andreeff M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M.S., Dimitrovsky E. Differentiation therapy of acute promyelotic leukemia with tretinolin (all-trans-retinoic-acid). N. Engl. J. Med. 1991; 324: 1385–1393
   PubMed Web of Science ®Google Scholar
• Mickley L.A., Bates S.E., Richert N.D., Currier S., Tanaka S., Foss F., Rosen N and, Fojo A.T. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. J. Bio. Chem. 1989; 264: 18031–18040
   PubMed Web of Science ®Google Scholar
• Bates S.E., Mickley L.A., Chen Y-N., Richert N., Rudick J., Biedler J.L., Fojo A.T. Expression of a drug resistance gene in human neuroblastoma cell lines: Modulation by retinoic acid-induced differentiation. Molec. Cell. Bio. 1989; 9: 4334–4344
   Google Scholar
• Lewis D.S., Thompson M., Hudson E., Liberman M.M., Samson D. Down's syndrome and acute megakaryoblastic leukemia. Acta Haematol. 1983; 70: 236–242
   PubMed Web of Science ®Google Scholar
• Zipursky A., Peeters M., Poon A. Megakaryoblastic leukemia and Down's syndrome—A review. Prog. Clin. Bio. Res. 1987; 246: 33–56
   PubMedGoogle Scholar
• Sato T., Fuse A., Eguchi M., Hayashi Y., Ryo R., Adachi M., Kishimoto Y., Teramura M., Mizoguchi H., Shima Y., Komori I., Sunami S., Okimoto Y., Nakajima H. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from Down's syndrome patient with acute megakaryoblastic leukaemia. Br. J. Haematol. 1989; 72: 184–190
   PubMed Web of Science ®Google Scholar
• Komatsu N., Suda T., Moroi M., Tokuyama N., Sakata Y., Okada M., Nishida T., Hirai Y., Sato T., Fuse A., Miura Y. Growth and differentiation of a human megakaryoblastic cell line, CMK. Blood 1989; 74: 42–48
   PubMed Web of Science ®Google Scholar
• Sunami S., Fuse A., Simizu B., Eguchi M., Hayashi Y., Sugita K., Nakazawa S., Okimoto Y, Sato T., Nakajima H. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome. Blood 1987; 70: 368–371
   PubMed Web of Science ®Google Scholar
• Sakaguchi M., Sato T., Groopman J.E. Human immunodeficiency virus infection of megakaryocytic cells. Blood 1991; 77: 481–485
   PubMed Web of Science ®Google Scholar
• Sugimoto Y., Asami N., Tsuruo T. Expression of P-glycoprotein mRNA in human gastric tumors. Jpn. J. Cancer Res. 1989; 80: 993–999
   PubMedGoogle Scholar
• Chomczynsky P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Hamada H., Tsuruo T. Functional role for the 170 to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Nat. Acad. Sci. USA 1986; 83: 7785–7789
   PubMed Web of Science ®Google Scholar
• Shima Y., Sato T., Nakajima H., Eguchi M., Fuse A. Inhibition of proliferation and induction of differentiation of a megakaryoblastic leukemia cell line, CMK cells by interferon-γ. The Biology of the Interferon System 1988, K. Kawade, S. Kobayashi. Kodansha Scientific Ltd, Tokyo 1989; 407–411
   Google Scholar
• Fuse A., Kakuda H., Shima Y., van Damme J., Billiau A., Sato T. Interleukin 6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK. Br. J. Haematol. 1991; 77: 32–36
   PubMed Web of Science ®Google Scholar
• Fairchild C.R., Ivy S.P., Kao-Shan C-S., Wang-Peng J., Rosen N., Israel M.A., Melera P.W., Cowan K.H., Goldsmith M.E. Isolation of amplified and overexpressed DNA sequences from adriamysin-resistant human breast cancer cells. Cancer Res. 1987; 47: 5141–5148
   PubMed Web of Science ®Google Scholar
• Ruiz J.C., von Choi K., Hoff D.D., Roninson I.B., Wahl G.M. Autonomously replicating episomes contain mdr-1 genes in a multidrug-resistant human cell line. Molec. Cell. Bio. 1989; 9: 109–115
   PubMed Web of Science ®Google Scholar
• Shen D.-W., Fojo A., Roninson I.B., Chin J.E., Richert N., Pastan I., Gottesman M.M. Human multidrug-resistant cell lines: Increased mdr-1 expression can precede gene amplication. Science 1986; 232: 643–645
   PubMed Web of Science ®Google Scholar
• Gerlach J.H., Kartner N., Bell D.R., Ling V. Multidrug resistance. Cancer. Surv. 1986; 5: 25–46
   PubMedGoogle Scholar
• Sugimoto Y., Tsuruo T. DNA-mediated transfer and cloning of a human multidrug-resistant gene of adriamycin-resistant myelogenous leukemia K562. Cancer. Res. 1987; 47: 2620–2625
   PubMed Web of Science ®Google Scholar
• Lemontt J.F., Azzaria M., Gros P. Increased mdr gene expression and decreased drug accumulation in multidrug-resistant human melanoma cells. Cancer Res. 1988; 48: 6348–6353
   PubMed Web of Science ®Google Scholar
• Tatsuta T., Naito M., Oh-Hara T., Sugawara I., Tsuruo T. Functional involvement of P-glycoprotein in blood-brain barrier. J. Bio. Chem. 1992; 267: 20383–20391
   PubMed Web of Science ®Google Scholar
• Yang C.P.H., De Pinho S.G., Greenberger L.M., Arecci R.J., Horwitz S.B. Progestron interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J. Bio. Chem. 1989; 264: 782–788
   PubMed Web of Science ®Google Scholar
• Ueda K., Okamura N., Hirai M., Tanigawa Y., Saeki T., Kioka N., Komano T., Hori R. Human P-glycoprotein transports cortisol, aldosterine, and dexamethasone, but not progesterone. J. Bio. Chem. 1992; 264: 24248–24252
   Google Scholar
• Warren L., Jardiller J.C., Ordentlich P. Secretion of lysozomal enzymes by drug-sensitive and multiple drug-resistant cells. Cancer Res. 1991; 51: 1996–2001
   PubMed Web of Science ®Google Scholar
• Sharma R.C., Inoue S., Riutekman J., Schimke R.T., Simoni R.D. Peptide transport by the multidrug resistance pump. J. Bio. Chem. 1992; 267: 5731–5734
   PubMed Web of Science ®Google Scholar
• De Lannoy I.A.M., Silverman M. The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycosidem digoxin. Biochem. Biophys. Res. Commun. 1992; 189: 551–557
   PubMed Web of Science ®Google Scholar
• Young P.R., Krasney P.A. Stimulation of interleukin 1p secretion in monkey cells by coexpression of the mammalian P-glycoprotein MDR1. Pathophysiology and Pharmacology of Cytokines, P. Ghezzi, A. Mantovani, 1992; 21–27, Biomedical Press
   Google Scholar
• Gupta S., Gollapudo S. P-Glycoprotein (MDR 1 gene Product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection. J. Clin. Immunol. 1993; 13: 289–301
   PubMed Web of Science ®Google Scholar
• Chaudhary P.M., Roninson I.B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991; 66: 85–94
   PubMed Web of Science ®Google Scholar
• Witokowsky J.M., Miller R.A. Increased function of P-glycoprotein in T lymphocyte subsets of aging mice. J. Immunol. 1993; 150: 1296–1306
   PubMed Web of Science ®Google Scholar
• Wood G., Lund L.A., Naik M., Ling V., Ochi A. Resistance of multidrug-resistant cell lines to natural killer-like cell mediated cytotoxicity. FASEB J. 1988; 2: 2791–2796
   PubMed Web of Science ®Google Scholar
• Chong AS-F., Markham P.M., Gebel H.M., Bines S.D., Coon J.S. Diverse multidrug-resistance-modification agents inhibit cytotoxic activity of natural killer cells. Cancer Immunol. Immunother. 1993; 36: 133–139
   PubMed Web of Science ®Google Scholar